|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-12-27
|
|
pubmed:abstractText |
Although BRCA1 and BRCA2 were identified in 1994 and 1995, respectively, to the authors' knowledge the optimal management of women with BRCA-associated breast carcinoma remains incompletely defined. The current study evaluates the appropriateness of breast-conserving therapy (BCT) in women with BRCA mutations.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
44-51
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15558796-Adult,
pubmed-meshheading:15558796-Aged,
pubmed-meshheading:15558796-Aged, 80 and over,
pubmed-meshheading:15558796-Breast Neoplasms,
pubmed-meshheading:15558796-Carcinoma,
pubmed-meshheading:15558796-Female,
pubmed-meshheading:15558796-Follow-Up Studies,
pubmed-meshheading:15558796-Genes, BRCA1,
pubmed-meshheading:15558796-Genes, BRCA2,
pubmed-meshheading:15558796-Germ-Line Mutation,
pubmed-meshheading:15558796-Humans,
pubmed-meshheading:15558796-Mastectomy,
pubmed-meshheading:15558796-Mastectomy, Segmental,
pubmed-meshheading:15558796-Middle Aged,
pubmed-meshheading:15558796-Neoplasms, Second Primary,
pubmed-meshheading:15558796-Patient Selection,
pubmed-meshheading:15558796-Prognosis,
pubmed-meshheading:15558796-Risk Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.
|
|
pubmed:affiliation |
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. robsonm@mskcc.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|
